静脉吸毒作为念珠菌血症风险因素在美国马萨诸塞州重新出现
研究回顾了马萨诸塞州中部一家三级医院7年内198例念珠菌血症病例,其中24例有静脉吸毒史。与非静脉吸毒患者相比,有静脉吸毒史者更易感染非白念珠菌、合并丙型肝炎及出现终末器官受累(包括心内膜炎和骨髓炎)。静脉吸毒似乎正重新成为侵袭性念珠菌病的风险因素。
要点
- 有静脉吸毒史的念珠菌血症患者更易感染非白念珠菌。
- 有静脉吸毒史者更易合并丙型肝炎感染。
- 有静脉吸毒史者更易出现终末器官受累,包括心内膜炎和骨髓炎。
核心结论
- 静脉吸毒似乎正重新成为侵袭性念珠菌病的风险因素。
研究设计与样本
- 回顾性分析马萨诸塞州中部一家三级医院7年内198例年龄>14岁的念珠菌血症病例。
主要发现
- 198例念珠菌血症患者中24例有静脉吸毒史。
- 与非静脉吸毒患者相比,有静脉吸毒史者更易感染非白念珠菌、合并丙型肝炎及出现终末器官受累(包括心内膜炎和骨髓炎)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The epidemic of illicit intravenous drug use (IVDU) in the United States has been accompanied by a surge in drug overdose deaths and infectious sequelae. Candida albicans infections were associated with injection of contaminated impure brown heroin in the 1970s-1990s; however, candidiasis accompanying IVDU became considerably rarer as the purity of the heroin supply increased. We reviewed cases of candidemia occurring over a recent 7-year period in persons >14 years of age at a tertiary care hospital in central Massachusetts. Of the 198 patients with candidemia, 24 cases occurred in patients with a history of IVDU. Compared with non-IVDU patients, those with a history of IVDU were more likely to have non-albicans Candida, be co-infected with hepatitis C, and have end-organ involvement, including endocarditis and osteomyelitis. Thus, IVDU appears to be reemerging as a risk factor for invasive candidiasis.
引用
- Poowanawittayakom N, Dutta A, Stock S, et al. Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA. Emerg Infect Dis. 2018. PMID: 29553923. doi:10.3201/eid2404.171807
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。